ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. OrsoBio Splurges With Four Concurrent L
ScripThe once-shocking $100m-plus venture capital round is not such a shock anymore in the biopharmaceutical sector, since the number of mega-rounds has increased over the last few years as drug developmen
ScripTakeda Pharmaceutical Co. Ltd. has acquired the private San Diego-based venture PvP Biologics Inc. , following promising early clinical results with the university spin-out’s candidate for celiac di
ScripAchilles Raises £100m In Series B Round Cancer immunotherapy company Achilles Therapeutics Ltd. raised £100m ($121m) in its Series B round. RA Capital led and was joined by founding investor Syncona